{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:39:23Z","timestamp":1782254363041,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T00:00:00Z","timestamp":1324684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s12253-011-9483-7","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T04:48:21Z","timestamp":1324615701000},"page":"607-614","source":"Crossref","is-referenced-by-count":27,"title":["Molecular Profiling of Parathyroid Hyperplasia, Adenoma and Carcinoma"],"prefix":"10.1007","volume":"18","author":[{"given":"Krist\u00f3f","family":"\u00c1rvai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Barti-Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Pet\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Kren\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Micsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"V\u00e9gs\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Perner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Szende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,24]]},"reference":[{"issue":"2","key":"9483_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/cncr.22790","volume":"110","author":"GG Fernandez-Ranvier","year":"2007","unstructured":"Fernandez-Ranvier GG, Khanafshar E, Jensen K et al (2007) Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110(2):255\u2013264","journal-title":"Cancer"},{"key":"9483_CR2","unstructured":"Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17 Suppl 2:N18-23"},{"key":"9483_CR3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200012213432508","volume":"343","author":"SJ Marx","year":"2000","unstructured":"Marx SJ (2000) Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343:1863\u20131875","journal-title":"N Engl J Med"},{"issue":"2","key":"9483_CR4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","volume":"115","author":"GG Fernandez-Ranvier","year":"2009","unstructured":"Fernandez-Ranvier GG, Khanafshar E, Tacha D et al (2009) Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer 115(2):334\u2013344","journal-title":"Cancer"},{"issue":"1","key":"9483_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/hupa.2003.55","volume":"34","author":"A Stojadinovic","year":"2003","unstructured":"Stojadinovic A, Hoos A, Nissan A et al (2003) Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol 34(1):54\u201364","journal-title":"Hum Pathol"},{"issue":"2","key":"9483_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02893463","volume":"10","author":"B Szende","year":"2004","unstructured":"Szende B, Farid P, V\u00e9gso G et al (2004) Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Pathol Oncol Res 10(2):98\u2013103","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"9483_CR7","first-page":"12","volume":"10","author":"MP Vargas","year":"1997","unstructured":"Vargas MP, Vargas HI, Kleiner DE et al (1997) The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol 10(1):12\u201317","journal-title":"Mod Pathol"},{"issue":"1","key":"9483_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03032405","volume":"11","author":"T Hadar","year":"2005","unstructured":"Hadar T, Shvero J, Yaniv E et al (2005) Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Pathol Oncol Res 11(1):45\u201349","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"9483_CR9","first-page":"137","volume":"50","author":"B Szende","year":"2006","unstructured":"Szende B, Arvai K, Pet\u00e1k I et al (2006) Changes in gene expression in the course of proliferative processes in the parathyroid gland. Magy Onkol 50(2):137\u2013140","journal-title":"Magy Onkol"},{"key":"9483_CR10","unstructured":"Solcia E, Kloppel G, Sobin LH (2000) Histological typing of endocrine tumours; international histological classification of tumours. WHO Ed. 2. Springer; p.48\u201355"},{"issue":"2","key":"9483_CR11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/edrv-3-2-218","volume":"3","author":"E Shane","year":"1982","unstructured":"Shane E, Bilezikian JP (1982) Parathyroid carcinoma: a review of 62 patients. Endocr Rev 3(2):218\u2013226","journal-title":"Endocr Rev."},{"issue":"12","key":"9483_CR12","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s002689900549","volume":"22","author":"G Favia","year":"1998","unstructured":"Favia G, Lumachi F, Polistina F et al (1998) Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg 22(12):1225\u20131230","journal-title":"World J Surg"},{"key":"9483_CR13","unstructured":"Hundahl SA, Fleming ID, Fremgen AM et al (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985\u20131995: a National Cancer Data Base Report. Cancer 1;86(3):538\u201344"},{"issue":"8","key":"9483_CR14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.20049","volume":"26","author":"NL Busaidy","year":"2004","unstructured":"Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26(8):716\u2013726","journal-title":"Head Neck"},{"issue":"20","key":"9483_CR15","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1158\/0008-5472.CAN-04-2063","volume":"64","author":"CJ Haven","year":"2004","unstructured":"Haven CJ, Howell VM, Eilers PH et al (2004) Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 64(20):7405\u20137411","journal-title":"Cancer Res"},{"key":"9483_CR16","doi-asserted-by":"crossref","unstructured":"Woodard GE, Lin L, Zhang JH et al (2005) Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression. Oncogene 10;24(7):1272\u20136","DOI":"10.1038\/sj.onc.1208274"},{"issue":"2","key":"9483_CR17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1677\/ERC-06-0092","volume":"14","author":"F Cetani","year":"2007","unstructured":"Cetani F, Pardi E, Ambrogini E et al (2007) Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocr Relat Cancer 14(2):493\u2013499","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"9483_CR18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00423-009-0511-y","volume":"394","author":"M Iacobone","year":"2009","unstructured":"Iacobone M, Masi G, Barzon L et al (2009) Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg 394(5):817\u2013825","journal-title":"Langenbecks Arch Surg"},{"key":"9483_CR19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/nar\/gkp991","volume":"38","author":"Y-J Yang","year":"2010","unstructured":"Yang Y-J, Han J-W, Youn H-D et al (2010) The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res 38:382\u2013390","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"9483_CR20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1677\/ERC-08-0066","volume":"15","author":"G Masi","year":"2008","unstructured":"Masi G, Barzon L, Iacobone M et al (2008) Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer 15(4):1115\u20131126","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"9483_CR21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4158\/EP09045.CRR1","volume":"15","author":"RY Shih","year":"2009","unstructured":"Shih RY, Fackler S, Maturo S et al (2009) Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation. Endocr Pract 15(6):567\u2013572","journal-title":"Endocr Pract"},{"issue":"5","key":"9483_CR22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P et al (2007) Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol 156(5):547\u2013554","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9483_CR23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill A, Clarkson A et al (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94(2):434\u2013441","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-011-9483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-011-9483-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-011-9483-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T07:58:17Z","timestamp":1561103897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-011-9483-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,24]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["9483"],"URL":"https:\/\/doi.org\/10.1007\/s12253-011-9483-7","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,24]]}}}